"Taking on practices that put fast-track development and marketing ahead of good medicine, this riveting book provides and insider's view of an industry in crisis, busting myths and explaining how the major pharmaceutical companies have suffered from a gambling addiction since the early 1980s. This isn't just another attack on Big Pharma's modus operandi. Find It, File It, Flog It digs deeper to expose the root cause of the drug industry's debilitating disease and proposes a commonsense cure"--B...
Plastics have occupied an important place in the modern medical industry. It has substituted traditional devices and products made of metal, other materials, and ceramics. Over recent years, increased reliance on transparent plastic pharmaceutical and medical products has produced remarkable breakthroughs that improve medical attention delivery and allow it to be more comfortable for the masses to live better and longer lives. The purpose of this handbook is to provide a strategic perspective on...
Microbiological Contamination Control in Aqueous-Based Non-Sterile Pharmaceuticals (Contamination control explained)
by Nigel Halls
Pharmaceutical Marketing (Financial Times Pharmaceuticals & Healthcare Publishing management reports)
Marketing with Success in Indonesia and the Philippines
by Stephen C. Harrison
New Technologies in Biopharmaceuticals
by Sarah Rickwood and Amanda Southworth
Recent Progress in Medicinal Plants (Search for Natural Drugs)
by J N Govil and V. K. Singh
Recent Progress in Medicinal Plants (Drug Development from Molecules)
by V. K. Singh and J N Govil
In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the U...
Mutant Ecologies traces the spinning of new synthetic threads into the web of life. It is a critical cartography of the shifting landscapes of capital accumulation conjured by recent developments in genomic science, genome editing and the biotech industry. CRISPR crops, fast-growing salmons, heat-resistant Slick™ cows, Friendly™ Mosquitoes, humanised mice, pigs growing human organs – these are but a few of the dazzling new life-forms that have recently emerged from corporate and university labo...
Unlock Your Influence and Success Eye-catching, bold, and welcoming: a red door is all of these things. But is your organization reflective of such traits? Karen Moore, founder and CEO of Moore Communications Group, is redefining advocacy and can help you influence public policy, drive your business objectives, and foster engagement in your brand equity. In behind the RED DOOR , Karen Moore provides you with the knowledge and tools to: understand the value of advocacy engagement for your organ...
Contract Manufacture and Analysis
Pharmaceutical Manufacturing (Processing and Packaging)
Pharmaceutical R&D Factbook
CMR International Pharmaceutical R&D Factbook